Baoqian Zhai
Yancheng, 224000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Systemic immune-inflammatory index predict short-term outcome in recurrent/metastatic and locally advanced cervical cancer patients treated with PD-1 inhibitor.
Journal: Scientific reports
Published: June 26, 2024
Correction: CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.
Journal: Molecular cancer
Published: October 23, 2023
CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.
Journal: Molecular cancer
Published: June 27, 2022
Fibroblast Growth Factor 11 Enables Tumor Cell Immune Escape by Promoting T Cell Exhaustion and Predicts Poor Prognosis in Patients with Lung Adenocarcinoma.
Journal: Journal of oncology
Published: May 25, 2022
VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo.
VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo.
Journal: Frontiers in pharmacology
Published: February 11, 2022
Predictive value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score and lymphocyte-to-monocyte ratio (LMR) in patients with non-small cell lung cancer after radical lung cancer surgery.
Journal: Annals of translational medicine
Published: April 02, 2021
Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer.
Journal: OncoTargets and therapy
Published: October 21, 2020
Relationship and prognostic significance between preoperative serum albumin to globulin ratio and CT features of non-small cell lung cancer.
Journal: European journal of radiology
Published: October 28, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026